Altered cytochrome P450 activities and expression levels in the liver and intestines of the monosodium glutamate-induced mouse model of human obesity.
- Authors
- Tomankova, Veronika; Liskova, Barbora; Skalova, Lenka; Bartikova, Hana; Bousova, Iva; Jourova, Lenka; Anzenbacher, Pavel; Ulrichova, Jitka; Anzenbacherova, Eva
- Year
- 2015
- Journal
- Life sciences
- PMID
- 25998026
- DOI
- 10.1016/j.lfs.2015.04.014
UNLABELLED: Cytochromes P450 (CYPs) are enzymes present from bacteria to man involved in metabolism of endogenous and exogenous compounds incl. drugs. Our objective was to assess whether obesity leads to changes in activities and expression of CYPs in the mouse liver, small intestine and colon. MAIN METHODS: An obese mouse model with repeated injection of monosodium glutamate (MSG) to newborns was used. Controls were treated with saline. All mice were sacrificed at 8 months. In the liver and intestines, levels of CYP mRNA and proteins were analyzed using RT-PCR and Western blotting. Activities of CYP enzymes were measured with specific substrates of human orthologous forms. KEY FINDINGS: At the end of the experiment, body weight, plasma insulin and leptin levels as well as the specific content of hepatic CYP enzymes were increased in obese mice. Among CYP enzymes, hepatic CYP2A5 activity, protein and mRNA expression increased most significantly in obese animals. Higher activities and protein levels of hepatic CYP2E1 and 3A in the obese mice were also found. No or a weak effect on CYPs 2C and 2D was observed. In the small intestine and colon, no changes of CYP enzymes were detected except for increased expression of CYP2E1 and decreased expression of CYP3A mRNAs in the colon of the obese mice. SIGNIFICANCE: Results of our study suggest that the specific content and activities of some liver CYP enzymes (especially CYP2A5) can be increased in obese mice. Higher activity of CYP2A5 (CYP2A6 human ortholog) could lead to altered metabolism of drug substrates of this enzyme (valproic acid, nicotine, methoxyflurane).
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. | 2019 | 29568101 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Impact of aging on the pharmacokinetic profile of everolimus in male mice. | Ozturk Civelek D et al. | — | 2026 | → |
| Potential impact of underlying diseases influencing ADME in nonclinical safety assessment. | Cho S et al. | — | 2024 | → |
| Effect of DSS-Induced Ulcerative Colitis and Butyrate on the Cytochrome P450 2A5: Contribution of the Microbiome. | Satka S et al. | — | 2022 | → |
| Obesity-related genomic instability and altered xenobiotic metabolism: possible consequences for cancer risk and chemotherapy. | Bankoglu EE et al. | — | 2022 | → |
| Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis. | Kuzin M et al. | — | 2021 | → |
| Dietary-Induced Obesity, Hepatic Cytochrome P450, and Lidocaine Metabolism: Comparative Effects of High-Fat Diets in Mice and Rats and Reversibility of Effects With Normalization of Diet. | Al Nebaihi HM et al. | — | 2020 | → |
| Impact of obese levels on the hepatic expression of nuclear receptors and drug-metabolizing enzymes in adult and offspring mice. | Wang P et al. | — | 2020 | → |
| A review of the alleged health hazards of monosodium glutamate. | Zanfirescu A et al. | — | 2019 | → |
| CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. | Wang K et al. | — | 2019 | → |
| Effects of short-term saffron (Crocus sativus L.) intake on the in vivo activities of xenobiotic metabolizing enzymes in healthy volunteers. | Begas E et al. | — | 2019 | → |
| Obesity: Pathophysiology, monosodium glutamate-induced model and anti-obesity medicinal plants. | Hernández Bautista RJ et al. | — | 2019 | → |
| Decreased expression of hepatic cytochrome P450 1A2 (CYP1A2) in a chronic intermittent hypoxia mouse model. | Zhang XB et al. | — | 2018 | → |
| Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment. | Alfarisi O et al. | — | 2018 | → |
| Impact of obesity and overweight on DNA stability: Few facts and many hypotheses. | Setayesh T et al. | — | 2018 | → |
| An integrated strategy for the quantitative analysis of endogenous proteins: A case of gender-dependent expression of P450 enzymes in rat liver microsome. | Shao Y et al. | — | 2017 | → |
| Effects of obesity on liver cytochromes P450 in various animal models. | Tomankova V et al. | — | 2017 | → |
| Sea ice-associated decline in body condition leads to increased concentrations of lipophilic pollutants in polar bears (Ursus maritimus) from Svalbard, Norway. | Tartu S et al. | — | 2017 | → |
| Hypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity Intervention. | Roth CL | — | 2015 | → |